Viewing Study NCT01390818

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:43 AM
Ignite Modification Date: 2026-01-11 @ 5:18 PM
Study NCT ID: NCT01390818
Status: COMPLETED
Last Update Posted: 2017-03-07
First Post: 2011-04-18
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Sponsor: EMD Serono
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Solid Tumor View
None Metastatic Solid Tumor View
None Breast Cancer View
None Non Small Cell Lung Cancer View
None Melanoma View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MEK inhibitor (Pimasertib) View
None PI3K/mTOR Inhibitor View
None Solid Tumor View
None Phase I View